Matinas BioPharma Holdings, Inc.·4

Sep 15, 4:18 PM ET

MANNINO RAPHAEL J 4

4 · Matinas BioPharma Holdings, Inc. · Filed Sep 15, 2017

Insider Transaction Report

Form 4
Period: 2017-09-11
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2017-09-11$1.41/sh+5,000$7,0501,424,565 total

Documents

1 file
  • 4
    mannino_fm4sept112017.xmlPrimary

    OWNERSHIP DOCUMENT